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W ith  interest we read the recent publication by William McGee 
and colleagues in which they conclude that arterial pressure- 
based cardiac output (APCO) measurement is comparable to 
intermittent thermodilution cardiac output (ICO) [1].
However, the Bland Altman plot of A P C O  versus ICO  shows 
a wide spread of data points w ith a percentage error of 42%. 
These large variations could lead to a com pletely different 
clinical management. Also, we disagree that a percentage 
error less than 28%  is a conservative requirement. By using 
an error-gram, limits of precision of ± 2 0 %  for both test and 
reference method give predicted limits of agreem ent of 
28 .3%  [2]. These limits should be respected when an 
alternative cardiac output measurement technique is evalua­
ted because limits of precision in excess of 20%  fo r a single 
technique are not clinically acceptable.
Furthermore, the authors state that they only consider a 
change in cardiac output of 30 %  or more clinically relevant. 
This is in contrast to daily clinical practice in which cardiac 
output changes of 10%  to 15%  are frequently used for 
making decisions regarding therapy. Also, they have 
calculated the change in cardiac output by dividing the delta 
cardiac output by the mean value before and after the change. 
In this way they have artificially decreased the relative change 
in cardiac output. Subsequently, in the plot showing the 
change in ICO  versus the change in APC O , it can be 
observed that when changes in ICO  of more than 15%  are 
analyzed, in only 35 %  of the cases did the A P C O  also change 
15%  or more in the same direction. Moreover, in 45%  of the 
cases the AP C O  changed in the opposite direction!
Based on the results of this study, we think that A P C O  is not 
accurate in measuring absolute values of cardiac output, nor 
in tracking changes in cardiac output in a general intensive 
care population.
Authors’ reply
W illiam  T M cG ee
Few data support the use of any therapy based on hemo­
dynamic variables to improve outcom e in intensive care unit 
(ICU) patients. In the recently com pleted FACTT trial, therapy 
based on cardiac output had no im pact on patient outcom e 
[3]. O ther trials targeting cardiac output as a treatment 
variable have had disappointing results [4].
In our study of ICU patients exhibiting a broad range of 
physiological variability, the limits of precision for ICO  are 
± 3 6 %  simply fo r consecutive measures of ICO. O ur ICO
m easurements are likely to reflect greater precision than 
usual practice as the investigators would frequently obtain 
additional (more than four) measurements in an attem pt to 
maximize reliability of the ICO  data during the trial, selecting 
the four measures in best agreement. In tw o trials involving 
more homogeneous groups of patients precision was similar 
[5,6].
A  change in cardiac output of 15%  or less should not prompt 
a change in management by itself. Basing treatment
APCO =  arterial pressure-based cardiac output; CCO =  continuous cardiac output; ICO =  intermittent thermodilution cardiac output; ICU =  inten­
sive care unit.
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decisions on cardiac output changes of 10%  to 15%  likely 
results in unnecessary hemodynamic manipulation of 
unknown clinical im pact and we would strongly discourage 
this practice in the absence of other clinically relevant 
information [7].
Both continuous m ethods (continuous cardiac output [CCO ] 
and APC O ) track dynamic change in cardiac output utilizing 
ICO  as a reference in a remarkably similar fashion. Although 
the absolute m agnitude of cardiac output change with either 
continuous measure is rarely identical to  a simultaneous ICO 
measurement, both continuous m ethods track AICO 
acceptably well w ithin ± 3 0 %  (96%  of the time for AP C O  and 
95 %  of the time for C C O  using this well accepted 
technology). Breukers and colleagues [5] found concordance 
of delta cardiac output in 75%  of determ inations comparing 
ICO  to APCO .
AP C O  is a promising minimally invasive technology that 
offers great safety advantages over standard techniques 
utilizing a pulmonary artery catheter when determ ination of 
cardiac output is thought to be important fo r patient care in 
the ICU.
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